一博科技(301366.SZ):和集成電路及半導體相關客户的合作在不斷加深
格隆匯7月7日丨一博科技(301366.SZ)近期在接待機構調研時表示,2022年度,公司主營業務覆蓋領域包括工業控制、網絡通信、醫療電子、集成電路、智慧交通、航空航天、人工智能等,各細分行業領域的營收佔比分別為30.93%、30.58%、10.27%、6.51%、5.16%、6.40%、4.84%。客户分佈領域廣泛,老客户合作穩定,當年來自新客户的收入佔比約10%左右。從今年上半年的訂單情況可以看出,工控類相關客户,需求在逐步回暖;智慧交通類客户,合作也在逐漸增加;此外我們和集成電路及半導體相關客户的合作也在不斷加深。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.